Previous Article | Next Article ![]()
Journal of Clinical Microbiology, February 2001, p. 691-695, Vol. 39, No. 2
The Institute for Adult Diseases, Asahi Life
Foundation, 1-9-14 Nishi-Shinjuku, Shinjuku-ku, Tokyo
160-0023,1 and Division of
Gastroenterology, Department of Internal Medicine, Faculty of
Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo,
113-8655,2 Japan
Received Recieved 17 July 2000/Returned for modification 20 September
2000/Accepted 11 November 2000
We developed a new method capable of detecting point mutations in
the 23S rRNA gene of Helicobacter pylori using a
LightCycler. Our method can detect a mutation in this gene in less than
1 h and can process many samples at once, thereby contributing to the selection of patients suitable for clarithromycin-based therapy.
The resistance of Helicobacter
pylori to clarithromycin is a major cause of failure in
eradication therapies (8); furthermore, mutations in the
23S rRNA gene (an A-to-G transition at nucleotide position 2143 [A2143G] or 2144 [A2144G]) have been found to confer resistance to
clarithromycin to H. pylori (3, 8, 10, 12). Reports indicate that the rate of eradication of H. pylori
with clarithromycin treatment is only 40% for mutant strains, whereas it is 85% for wild-type strains (6).
To date, the detection of mutations in the H. pylori 23S
rRNA gene is mainly performed by PCR, followed by digestion with restriction enzymes. The resulting DNA fragments are separated on
agarose or acrylamide gels, and the presence of a mutation is
determined by the pattern of the restriction fragment length polymorphism (RFLP) by PCR-RFLP analysis (6, 7). This
detection procedure is, however, time-consuming and requires
optimization of the PCR. In addition, contamination of the amplified
product can also cause false-positive results. Recently, a new
high-speed thermal cycler that uses glass capillaries (LightCycler;
Roche Diagnostics, Tokyo, Japan) has been introduced. Using this
recently introduced machine along with attached fluorescenct probes, we have established a new method that detects point mutations in the 23S
rRNA gene of H. pylori. We further examined the sensitivity and specificity of this method by comparison with PCR-RFLP analysis as
a "gold standard" and analysis of clinical samples (gastric tissue)
for the presence of mutant H. pylori strains.
Gastric tissues.
Gastric tissue was taken from 186 patients
with epigastralgia during gastric endoscopy examination, and a rapid
urease test was performed with a Helicocheck kit (Otsuka
Pharmaceutical, Tokyo, Japan). DNA was isolated from each tissue with a
QIAamp DNA mini kit (Qiagen, Tokyo, Japan) according to the
manufacturer's protocol. The isolated DNA was then dissolved in 20 µl of 1× TE buffer (10 mM Tris-HCl, 1 mM EDTA [pH 8.0]) and stored
at
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.2.691-695.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Rapid Detection of Mutations in the 23S rRNA
Gene of Helicobacter pylori That Confers Resistance
to Clarithromycin Treatment to the Bacterium
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
20°C until use.
Amplification and melting analysis of 23S rRNA gene of H. pylori using the LightCycler.
The primers used for PCR of
the 23S rRNA gene of H. pylori (GenBank accession no.
U27270) were CRFL-1 (5'-ATGAATGGCGTAACGAGAT-3'; nucleotides
2051 to 2070) and CRRL-2 (5'-ACACTCAACTTGCGATTCC-3'; nucleotides 2410 to 2391), and the result was a 360-bp product (Fig. 1). In addition, two kinds of
probes (detection probe MP-W and anchor probe AP-2186) were included in
the PCR mixture. The detection probe was 5' labeled with LC-Red 640 and
3' phosphorylated, and the anchor probe was 3' labeled with fluorescein
isothiocyanate. The latter was located downstream of the former at a
distance of 1 nucleotide. The locations of these primers and probes are shown in Fig. 1.
|
dF/dT) (see Fig. 2).
Standard DNA. Standard DNAs were synthesized in vitro by PCR (with primers CRFL-1 and CRR1-2) with DNAs from wild-type strains and strains with the A2143G and A2144G mutations as templates. The sequences of these standard DNAs were in complete accordance with those reported for the 23S rRNA gene of H. pylori in GenBank (accession number U27270). These DNAs were used for each experiment.
Melting analysis using DNA standards. With each standard DNA (DNAs of the wild type and the strains with the A2143G and A2144G mutations), a melting analysis was done with wild-type-specific detection probes (MP-W) as well as A2143G or A2144G mutation-specific detection probes (MP-2143 and MP-2144, respectively) (see Fig. 2).
Sensitivity in detecting mutant strains either by RFLP analysis or with the Light Cycler. In order to clarify the sensitivity of detection of mutant H. pylori among wild-type strains mutant DNA (from strains with either the A2143G or the A2144G mutations), synthesized as described above, was mixed with the DNA of the wild-type strain at ratios of 1:1, 1:1/2, 1:1/10, 1:1/20, and 1:1/50. These mixtures were processed for melting analysis with the LightCycler.
PCR-RFLP analysis. PCR-RFLP analysis was performed as described by Maeda et al. (6) with primers CRF-4 (5'-AGT GGA GGT GAA AATTCC-3'; nucleotides 2105 to 2122) and CRR-1 (5'-TAA GAG CCA AAG CCC TTA C-3'; nucleotides 2239 to 2221), resulting in a 135-bp product. PCR was performed in a thermal cycler (GeneAmp PCR system 9600; Applied Biosystems) with a 50-µl volume containing 2 µl of sample DNA, 5 µl of 10× PCR buffer (500 mM KCl, 100 mM Tris-HCl [pH 8.3], 15 mM MgCl2, 0.01% [wt/vol] gelatin), 0.5 µl each of CRF-4 and CRR-1 at 25 mM, 0.4 µL of a 25 mM deoxynucleoside triphosphate mixture, and 1 U of Taq DNA polymerase (Applied Biosystems). After heating of the mixture at 94°C for 5 min, PCR was performed for 34 cycles, with denaturation at 94°C for 30 s and extension at 57°C for 30 s, followed by incubation at 72°C for 4 min. The PCR product was digested with either the BsaI or the MboII restriction enzyme and was then electrophoresed on an acrylamide gel. The presence of the mutant was detected by examination of the patterns of the restricted fragments. While PCR products derived from the mutant were digested with either BsaI (mutant with the A2144G mutation) or MboII (mutant with the A2143G mutation), this was not possible for the wild-type strain.
| |
RESULTS |
|---|
|
|
|---|
Melting analysis of wild-type strain and two kinds of mutants with
mutations in the 23S rRNA gene.
By using standard DNAs, including
those of the wild type and mutants with the A2143G and A2144G
mutations, a melting analysis was performed. By using M-WP, the
fluorescence emitted by the mutant strains declined more rapidly than
that emitted by the wild-type strain. Figure
2 shows the melting peaks of each
standard DNA, with distinct peaks at different temperatures. In
addition, by using MP-2144 or MP-2143 as the detection probe, the
presence of each mutant strain could be clarified (Fig. 2).
|
Detection of mutants among wild-type H. pylori.
As
shown in Fig. 3, the mutant with the
A2143G mutation, as well as the mutant with the A2144G mutation (data
not shown), could be detected when it contaminated a mixture with the
wild type at a level of as little as 10%.
|
MIC for H. pylori and detection of mutants by melting
analysis.
Table 1 shows the
correlation between the genotypes of the H. pylori strains
and the MIC of clarithromycin. All mutant H. pylori isolates
were resistant to clarithromycin.
|
Detection of H. pylori mutants by PCR-RFLP analysis and melting analysis. Of 186 patients, H. pylori was detected in 151 patients with the Helicocheck kit. The 23S rRNA gene of H. pylori was amplified from all 151 Helicocheck-positive patients but not the 35 Helicocheck-negative patients.
If the existence of a mutant was suspected, the melting analysis was repeated with mutant-specific detection probes (MP-2143 or MP-2144), for clarification of the mutant type (Fig. 2). Using a combination of three kinds of probes, we examined strains for the presence of the mutant 23S rRNA gene. One hundred nineteen patients had wild-type strains only, 19 patients had mutant strains only, and 13 patients had both wild-type and mutant strains (Table 2). These results were in accordance with the results obtained by PCR-RFLP analysis.
|
| |
DISCUSSION |
|---|
|
|
|---|
For the LightCyler melting analysis, we used a long anchor probe (a 36-mer) along with a second shorter probe (an 18-mer) for the purpose of recognizing adjacent sequences with the shorter probe lying over the mutation site. When these probes hybridize with the PCR product within a 1-nucleotide interval, fluorescence is emitted by fluorescence resonance energy transfer (4). After completion of the PCR, the temperature was slowly raised from 50 to 80°C. Due to the great stability of the anchor probe, a loss of fluorescence occurs as the shorter probe melts off the template. Meanwhile, the wild-type-specific detection probe dissociates from the mutant-specific detection probe at a temperature lower than that for the wild-type sequence. A single-base mismatch under the detection probe results in a shift in the melting temperature to a lower temperature (1). This shift leads to another peak at a temperature lower than that for the wild-type strain (Fig. 2). By changing the kinds of detection probes, we can determine the presence of mutants with the A2143G and A2144G mutations.
The A2143C mutation, recently reported by Stone et al. (9) and Occhialini et al. (8), was not searched for in the present study because Matsuoka et al. (7) and Maeda et al. (5) reported that the mutation was not detected in either 82 or 412 strains, respectively, isolated from gastric tissue derived from Japanese patients. However, by using a detection probe which is hybridized with the strain with the A2143C mutation, the mutation could be detected by our method. We are preparing the probe and examining whether the mutation was detected among strains from Japanese patients.
As shown in Fig. 3, LightCycler melting analysis can detect mutants when they are present among wild-type strains at a level of as little as 10%. In addition, the ratio of contaminant mutants among wild-type strains can be estimated by comparing the melting curves with those obtained by using a mixture of standard DNAs (Fig. 3).
The sensitivity of detection of the mutant between PCR-RFLP analysis and LightCycler melting analysis was compared with 186 gastric tissue specimens. The results obtained by either method were comparable for all specimens. Our method could be as useful as PCR-RFLP analysis.
By using a LightCycler, the whole process was completed within 40 min. Due to the quick adaptation of temperature in the glass capillary (high surface-to-volume ratio), PCR can occur under quicker cycling conditions. Moreover, different from the PCR-RFLP technique, we need not deal with the amplified product once the reaction mixture is set in the LightCycler. Therefore, this simple procedure results in less chance of contamination and eliminates the need to perform a digestion with restriction enzymes.
As shown at Table 1, mutant H. pylori isolates were all resistant to clarithromycin. Therefore, our method could predict the presence of a clarithromycin-resistant strain before cultural data for H. pylori are obtained.
The coexistence of wild-type and mutant strains of H. pylori has been reported in several papers (2, 7, 11, 13, 14). Also, reportedly, clarithromycin-resistant and clarithromycin-sensitive strains do coexist in the same patient (13, 14), even among patients with no history of clarithromycin exposure (7). On the other hand, it has been observed that failed therapy with clarithromycin-based regimens may cause antimicrobial resistance in H. pylori (2, 11). Although the mechanism through which the clarithromycin-resistant strain appears during treatment remains to be clarified, our method may help to further elucidate this mechanism. In addition, the possibility of the existence of a heterozygous strain, with only one of two 23S rRNA genes containing a base substitution, could not be denied.
In conclusion, our method can easily detect the presence of a clarithromycin-resistant strain and can also process many samples at once, thereby contributing to the identification of those patients suitable for clarithromycin-based therapy for the treatment of H. pylori infection.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: The Institute for Adult Diseases, Asahi Life Foundation, 1-9-14 Nishi-Shinjuku, Shinjuku-ku, Tokyo 160-0023, Japan. Phone: 81-3-3343-2151. Fax: 81-3-3344-6275. E-mail: m-matsumura{at}asahi-life.or.jp.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Aslanidis, C., M. Nauck, and G. Schmitz. 1999. High-speed prothrombin G-A 20210 and methylenetetrahydrofolate reductase C-T 677 mutation detection using real-time fluorescence PCR and melting curves. BioTechniques 27:234-238[Medline]. |
| 2. | Enroth, H., B. Bjorkholm, and L. Engstrand. 1999. Occurrence of resistance mutation and clonal expansion in Helicobacter pylori multiple-strain infection: a potential risk in clarithromycin-based therapy. Clin. Infect. Dis. 28:1305-1307[Medline]. |
| 3. | Hulten, K., A. Gibreel, and L. Engstrand. 1997. Macrolide resistance in Helicobacter pylori: mechanism and stability in strains from clarithromycin-treated patients. Antimicrob. Agents Chemother. 41:2550-2553[Abstract]. |
| 4. | Livak, K. J., S. J. A. Flood, J. Marmaro, W. Giusti, and K. Deetz. 1995. Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization. PCR Methods Appl. 4:357-362[Medline]. |
| 5. |
Maeda, S.,
H. Yoshida,
H. Matsunaga,
K. Ogura,
O. Kawamata,
Y. Shiratori, and M. Omata.
2000.
Detection of clarithromycin-resistant Helicobacter pyroli strains by a preferential homoduplex formation assay.
J. Clin. Microbiol.
38:210-214 |
| 6. |
Maeda, S.,
H. Yoshida,
K. Ogura,
F. Kanai,
Y. Shiratori, and M. Omata.
1998.
Helicobacter pyroli specific nested PCR assay for the detection of 23S rRNA mutation associated with clarithromycin resistance.
Gut
43:317-321 |
| 7. |
Matsuoka, M.,
Y. Yoshida,
K. Hayakawa,
S. Fukuchi, and K. Sugano.
1999.
Similtaneous colonisation of Helicobacter pylori with and without mutations in the 23S rRNA gene in patients with no history of clarithromycin exposure.
Gut
45:503-507 |
| 8. | Occhialini, A., M. Urdaci, F. Doucet-Populaire, C. M. Bebear, H. Lamouliatte, and F. Megraud. 1997. Macrolide resistance in Helicobacter pylori: rapid detection of point mutations and assays of macrolide binding to ribosomes. Antimicrob. Agents Chemother. 41:2724-2728[Abstract]. |
| 9. | Stone, G. G., D. Shortridge, R. K. Flamm, J. Versalovic, J. Beyer, K. Idler, L. Zulawinski, and S. K. Tanaka. 1996. Identification of a 23S rRNA gene mutation in clarithromycin-resistant Helicobacter pylori. Helicobacter 1:227-228[Medline]. |
| 10. | Talor, N. S., J. G. Fox, N. S. Akopyrants, D. E. Berg, N. Thompson, B. Shames, L. Yan, E. Fontham, F. Janney, F. M. Hunter, and P. Correa. 1995. Long-term colonization with single and multiple strains of Helicobacter pylori assessed by DNA fingerprinting. J. Clin. Microbiol. 33:918-923[Abstract]. |
| 11. | Vakil, N., B. Hahn, and D. McSorley. 1998. Clarithromycin-resistant Helicobacter pylori in patients with duodenal ulcer in the United States. Am. J. Gastroenterol. 93:1432-1435[CrossRef][Medline]. |
| 12. | Versalovic, J., D. Shortridge, K. Kibler, M. V. Griffy, J. Beyer, R. K. Flamm, S. K. Tanaka, D. Y. Graham, and M. F. Go. 1996. Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob. Agents Chemother. 40:477-480[Abstract]. |
| 13. |
Wang, G. E.,
Q. Jiang, and D. E. Taylor.
1998.
Genotypic characterization of clarithromycin-resistant and -susceptible Helicobacter pylori strains from the same patient demonstrates existence of two unrelated isolates.
J. Clin. Microbiol.
36:2730-2731 |
| 14. |
Wang, G. E.,
M. S. Rahman,
M. Z. Humayun, and D. E. Taylor.
1999.
Multiplex sequence analysis demonstrates the competitive growth advantage of the A-to-G mutants of clarithromycin-resistant Helicobacter pylori.
Antimicrob. Agents Chemother.
43:683-685 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»